Biohaven Ltd — Quarterly Cash Flow (NYSE:BHVN) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Total assets 615.11 M458.95 M550.41 M409.12 M451.45 M Total liabilities 191.67 M199.45 M415.83 M426.28 M399.38 M Total equity 423.44 M259.5 M134.59 M-17.16 M52.07 M Total liabilities & shareholders' equities 615.11 M458.95 M550.41 M409.12 M451.45 M Total debt ——257.07 M268.27 M238.9 M Net debt ——-147.91 M8.05 M-80.24 M

뉴스

Biohaven: Downgrade To Hold On Troriluzole Setback And Obesity Data 2nd Half 2026 (BHVN)

레이먼드 제임스, 경쟁사 데이터 발표 후 Biohaven에 ’Strong Buy’ 의견 유지

Raymond James reiterates Strong Buy on Biohaven stock after competitor data

uniQure stock surges 36% on FDA official’s departure

FDA 백신·유전자치료 부서장 퇴임에 uniQure 주가 36% 급등

What's Going On With Biohaven Stock On Monday? - Biohaven (NYSE:BHVN)

Biohaven 목표 주가 $10로 하향 조정

Biohaven stock price target lowered to $10 by H.C. Wainwright

리링크 파트너스, 바이오헤이븐 파마에 ’아웃퍼폼’ 투자의견 유지

Leerink Partners reiterates Biohaven Pharma stock Outperform rating

RBC 캐피탈, 바이오헤이븐 파마 목표 주가 상향

RBC Capital raises Biohaven Pharma stock price target on model tweaks